07:19 AM EDT, 06/23/2026 (MT Newswires) -- Brand Engagement Network ( BNAI ) said Tuesday the Skye Salud artificial intelligence medical evidence platform has advanced to phase 2 of its clinical evaluation program in Mexico and expanded into primary care use cases.

The platform, which is being developed in partnership with Grupo Skye and KNOBLOCH Information Group, retrieves clinical data from verified medical publications and clinical guidelines to aid healthcare professionals, the company said.

Phase 2 follows the phase 1 rheumatology testing and will evaluate the platform across a broader range of clinical topics and physician information needs, including Spanish language clinical content for the Mexican healthcare environment, Brand Engagement Network ( BNAI ) said.

Shares of the company were down 1.4% in Tuesday premarket activity.